Current status of cardiac manifestations in Fabry disease and their treatment

In the present paper, we discuss cardiac symptoms in Fabry patients, the main imaging and laboratory methods to diagnose myocardial involvement in this disease. In the second part, we present the main treatment options in Fabry patients, including enzyme replacement therapy, substrate reduction trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Radulescu, Dan, Buzdugan, Elena, Stoicescu, Lauretiu, Grosu, Alin, Radulescu, Maria L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411827/
https://www.ncbi.nlm.nih.gov/pubmed/34527902
http://dx.doi.org/10.15386/mpr-2221
_version_ 1783747354692681728
author Radulescu, Dan
Buzdugan, Elena
Stoicescu, Lauretiu
Grosu, Alin
Radulescu, Maria L
author_facet Radulescu, Dan
Buzdugan, Elena
Stoicescu, Lauretiu
Grosu, Alin
Radulescu, Maria L
author_sort Radulescu, Dan
collection PubMed
description In the present paper, we discuss cardiac symptoms in Fabry patients, the main imaging and laboratory methods to diagnose myocardial involvement in this disease. In the second part, we present the main treatment options in Fabry patients, including enzyme replacement therapy, substrate reduction treatment, chaperone therapy, gene treatment.
format Online
Article
Text
id pubmed-8411827
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-84118272021-09-14 Current status of cardiac manifestations in Fabry disease and their treatment Radulescu, Dan Buzdugan, Elena Stoicescu, Lauretiu Grosu, Alin Radulescu, Maria L Med Pharm Rep Articles In the present paper, we discuss cardiac symptoms in Fabry patients, the main imaging and laboratory methods to diagnose myocardial involvement in this disease. In the second part, we present the main treatment options in Fabry patients, including enzyme replacement therapy, substrate reduction treatment, chaperone therapy, gene treatment. Iuliu Hatieganu University of Medicine and Pharmacy 2021-08 2021-08-10 /pmc/articles/PMC8411827/ /pubmed/34527902 http://dx.doi.org/10.15386/mpr-2221 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
spellingShingle Articles
Radulescu, Dan
Buzdugan, Elena
Stoicescu, Lauretiu
Grosu, Alin
Radulescu, Maria L
Current status of cardiac manifestations in Fabry disease and their treatment
title Current status of cardiac manifestations in Fabry disease and their treatment
title_full Current status of cardiac manifestations in Fabry disease and their treatment
title_fullStr Current status of cardiac manifestations in Fabry disease and their treatment
title_full_unstemmed Current status of cardiac manifestations in Fabry disease and their treatment
title_short Current status of cardiac manifestations in Fabry disease and their treatment
title_sort current status of cardiac manifestations in fabry disease and their treatment
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411827/
https://www.ncbi.nlm.nih.gov/pubmed/34527902
http://dx.doi.org/10.15386/mpr-2221
work_keys_str_mv AT radulescudan currentstatusofcardiacmanifestationsinfabrydiseaseandtheirtreatment
AT buzduganelena currentstatusofcardiacmanifestationsinfabrydiseaseandtheirtreatment
AT stoicesculauretiu currentstatusofcardiacmanifestationsinfabrydiseaseandtheirtreatment
AT grosualin currentstatusofcardiacmanifestationsinfabrydiseaseandtheirtreatment
AT radulescumarial currentstatusofcardiacmanifestationsinfabrydiseaseandtheirtreatment

Ejemplares similares